Effect of Nitric Oxide on Naphthoquinone Toxicity in Endothelial Cells: Role of Bioenergetic Dysfunction and Poly(ADP-ribose) Polymerase Activation

被引:23
|
作者
Broniowska, Katarzyna A. [1 ]
Diers, Anne R. [1 ]
Corbett, John A. [2 ]
Hogg, Neil [1 ]
机构
[1] Med Coll Wisconsin, Dept Biophys, Redox Biol Program, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA
基金
美国国家卫生研究院;
关键词
OXIDATIVE STRESS; DNA-DAMAGE; MITOCHONDRIAL DYSFUNCTION; CELLULAR BIOENERGETICS; SUPEROXIDE GENERATION; NITROSATIVE STRESS; INDUCED APOPTOSIS; S-NITROSOTHIOLS; CYTO-TOXICITY; REDOX STATUS;
D O I
10.1021/bi400342t
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
When produced at physiological levels, reactive oxygen species (ROS) can act as signaling molecules to regulate normal vascular function. Produced under pathological conditions, ROS can contribute to the oxidative damage of cellular components (e.g., DNA and proteins) and trigger cell death. Moreover, the reaction of superoxide with nitric oxide (NO) produces the strong oxidant peroxynitrite and decreases NO bioavailability, both of which may contribute to activation of cell death pathways. The effects of ROS generated from the 1,4-naphthoquinones alone and in combination with NO on the activation status of poly(ADP-ribose) polymerase (PARP) and cell viability were examined. Treatment with redox cycling quinones activates PARP, and this stimulatory effect is attenuated in the presence of NO. Mitochondria play a central role in cell death signaling pathways and are a target of oxidants. We show that simultaneous exposure of endothelial cells to NO and ROS results in mitochondrial dysfunction, ATP and NAD(+) depletion, and cell death. Alone, NO and ROS have only minor effects on cellular bioenergetics. Further, PARP inhibition does not attenuate reduced cell viability or mitochondrial dysfunction. These results show that concomitant exposure to NO and ROS impairs energy metabolism and triggers PARP-independent cell death. While superoxide-mediated PARP activation is attenuated in the presence of NO, PARP inhibition does not modify the loss of mitochondrial function or adenine and pyridine nucleotide pools and subsequent bioenergetic dysfunction. These findings suggest that the mechanisms by which ROS and NO induce endothelial cell death are closely linked to the maintenance of mitochondrial function and not overactivation of PARP.
引用
收藏
页码:4364 / 4372
页数:9
相关论文
共 50 条
  • [1] Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation
    Francisco Garcia Soriano
    László Virág
    Prakash Jagtap
    Éva Szabó
    Jon G. Mabley
    Lucas Liaudet
    Anita Marton
    Dale G. Hoyt
    Kanneganti G. K. Murthy
    Andrew L. Salzman
    Garry J. Southan
    Csaba Szabó
    Nature Medicine, 2001, 7 : 108 - 113
  • [2] Diabetic endothelial dysfunction:: the role of poly(ADP-ribose) polymerase activation
    Soriano, FG
    Virág, L
    Jagtap, P
    Szabó, É
    Mabley, JG
    Liaudet, L
    Marton, A
    Hoyt, DG
    Murthy, KGK
    Salzman, AL
    Southan, GJ
    Szabó, C
    NATURE MEDICINE, 2001, 7 (01) : 108 - 113
  • [3] Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation
    Szabo, C
    Soriano, FG
    Virag, L
    Jagtap, P
    Szabo, E
    Mabley, J
    Liaudet, L
    Marton, A
    Salzman, A
    FASEB JOURNAL, 2001, 15 (04): : A215 - A215
  • [4] NITRIC-OXIDE TOXICITY AND POLY(ADP-RIBOSE)POLYMERASE
    KOLB, H
    SCIENCE, 1994, 265 (5173) : 722 - 723
  • [5] Endothelial dysfunction in aging animals:: the role of poly(ADP-ribose) polymerase activation
    Pacher, P
    Mabley, JG
    Soriano, FG
    Liaudet, L
    Komjáti, K
    Szabó, C
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (06) : 1347 - 1350
  • [6] Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation
    Pacher, P
    Soriano, FG
    Komjati, K
    Mabley, JG
    Szabo, C
    FASEB JOURNAL, 2002, 16 (04): : A242 - A242
  • [7] NITRIC-OXIDE TOXICITY AND POLY(ADP-RIBOSE)POLYMERASE - REPLY
    SNYDER, SH
    SCIENCE, 1994, 265 (5173) : 723 - 723
  • [8] The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes
    Pacher, P
    Liaudet, L
    Soriano, FG
    Mabley, JG
    Szabó, É
    Szabó, C
    DIABETES, 2002, 51 (02) : 514 - 521
  • [9] Angiotensin II-Mediated Endothelial Dysfunction: Role of Poly(ADP-ribose) Polymerase Activation
    Csaba Szabó
    Pál Pacher
    Zsuzsanna Zsengellér
    Anne Vaslin
    Katalin Komjáti
    Rita Benkö
    Min Chen
    Jon G. Mabley
    Márk Kollai
    Molecular Medicine, 2004, 10 : 28 - 35
  • [10] Angiotensin II-mediated endothelial dysfunction:: Role of poly(ADP-ribose) polymerase activation
    Szabó, C
    Pacher, P
    Zsengellér, Z
    Vaslin, A
    Komjáti, K
    Benkö, R
    Chen, M
    Mabley, JG
    Kollai, M
    MOLECULAR MEDICINE, 2004, 10 (1-6) : 28 - 35